References
- Cupp EW, Sauerbrey M, Richards F. Elimination of human
onchocerciasis: History of progress and current feasibility using ivermectin
(Mectizan®) monotherapy. Acta Trop. 2011; 120(Suppl): 100-8. PubMed | Google
Scholar
- Wolstenholme AJ, Rogers AT. Glutamate-gated chloride
channels and the mode of action of the avermectin/milbemycin
anthelmintics. Parasitology. 2005; 131(Suppl): 85-95. PubMed | Google
Scholar
- Cauchie C, Rutsaert J, Thys O, Bonnyns M, Perrier
O. Encéphalite à Loa-loa, traitée par l'association de cortisone et de
carbamazine. Rev Belg Pathol Med Exp. 1965; 31: 232-44. Google
Scholar
- Kamgno J, Boussinesq M, Labrousse F, Nkegoum B,
Thylefors BI, Mackenzie CD. Case report: Encephalopathy
after Ivermectin Treatment in a Patient Infected with
Loa Loa and Plasmodium spp. Am
J Trop Med Hyg. 2008; 78(4): 546-51. Google
Scholar
- Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno
J, Ngoumou P, Chippaux JP. Three probable cases of
loa loa encephalopathy following ivermectin treatment
for onchocerciasis. Am J Trop Med
Hyg. 1998; 58(4): 461-9. PubMed | Google
Scholar
- Nana AY Twum-Danso. Loa loa encephalopathy temporally
related to ivermectin administration reported from
onchocerciasis mass treatment programs from 1989 to 2001: implications
for the future. Filaria
Journal. 2003; 2(Suppl 1): 1-7. PubMed | Google
Scholar
- Diawara L, Traore MO, Badji A, Bissan Y, Doumbia
K et al. Feasibility of Onchocerciasis Elimination
with Ivermectin Treatment in Endemic Foci in Africa:
First Evidence from Studies in Mali and Senegal.
PLoS Negl Trop Dis. 2009; 3(7): e497. PubMed | Google
Scholar
- OMS, Programme Mondial pour l'Elimination de la Filariose Lymphatique (GPELF). Rapport de situation 2000-2009 et plan stratégique. 2010-2020. WHO/HTM/NTD/PCT/2010. Google Scholar